December 22, 2011
Medical Device Daily
The Prometheus v. Mayo case was argued at the U.S. Supreme Court earlier in December, and while many of the justices’ questions seemed to reflect positions they were expected to hold, Chief Justice John Roberts asked questions that have prompted at least one patent attorney to speculate that Roberts might find the technology being litigated ineligible for patent protection, which would have a detrimental impact on the future of patents related to diagnostics and personalized medicine. Finnegan partner Denise DeFranco stated if the Court reversed the Federal Circuit, the outcome “could have major implications,” adding, “if they say this claim is invalid, no matter how narrowly they state that, there are a lot of claims like this one” that would be affected
Award/Ranking
Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked
May 28, 2026
Commentary
May 20, 2026
Award/Ranking
Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award
May 13, 2026
Press Release
Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination
May 11, 2026
Award/Ranking
Associates Rank Finnegan “Best of the Best” in BTI Associate Satisfaction Survey
May 7, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.